Name | Value |
---|---|
Revenues | 33.5M |
Cost of Revenue | 27.0M |
Gross Profit | 6.4M |
Operating Expense | 49.9M |
Operating I/L | -43.5M |
Other Income/Expense | -0.3M |
Interest Income | 2.6M |
Pretax | -43.8M |
Income Tax Expense | 0.2M |
Net Income/Loss | -44.0M |
Outset Medical, Inc. develops the Tablo Hemodialysis System, a compact console that integrates water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The system is the primary source of revenue for the company, providing a comprehensive solution for hemodialysis. Outset Medical, Inc. focuses on the development and commercialization of its innovative hemodialysis system to generate profits.